Clathrin heavy chain (CHC) staining for the diagnosis of small hepatocellular carcinoma(◆)(◆)Abstract published under permission of Wiley-Blackwell.

by David F. Schaeffer, Nahum Méndez-Sánchez
Published 2011-07-01

Primary hepatic perivascular epithelioid tumor (PEComa)

by David F. Schaeffer, Michael P. Poulin
Published 2016-05-01

Off-label use of common predictive biomarkers in gastrointestinal malignancies: a critical appraisal

by Basile Tessier-Cloutier, Ellen Cai, David F. Schaeffer
Published 2019-06-01

Mucinous cystic neoplasm of the pancreas with type-1 autoimmune pancreatitis-like lesion

by Kevin Gowing, David F. Schaeffer, Hui-Min Yang
Published 2019-11-01

Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity

by Kate O’Connor, Joanna C. Walsh, David F. Schaeffer
Published 2014-05-01

Familial Adenomatous Polyposis—Rendering a Diagnosis Based on Recognition of an Unusual Primary Thyroid Neoplasm

by David F. Schaeffer, Eric M. Yoshida, David A. Owen, Kenneth W. Berean
Published 2011-01-01

Benign Tailgut Cyst Masquerading as a Hemorrhoid

by Joyce M Leo, Kate M O’Connor, Michael Pezim, Alexander Nagy, David F Schaeffer
Published 2014-01-01

CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome

by Carol Cremin, Sarah Howard, Lyly Le, Aly Karsan, David F. Schaeffer, Daniel Renouf, Kasmintan A. Schrader
Published 2018-03-01

LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma

by David F. Schaeffer, Maziar Riazy, Kuljit S. Parhar, Johnny H. Chen, Vincent Duronio, Tatsuya Sawamura, Urs P. Steinbrecher
Published 2009-08-01

Surgical morbidity in severely obese liver transplant recipients - A single Canadian Centre Experience

by David F. Schaeffer, MD, Eric M. Yoshida, Andrezj K. Buczkowski, Stephen W. Chung, Urs P. Steinbrecher, Siegfried E. Erb, Charles H. Scudamore
Published 2009-01-01

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

by Basile Tessier-Cloutier, Steve E. Kalloger, Mohammad Al-Kandari, Katy Milne, Dongxia Gao, Brad H. Nelson, Daniel J. Renouf, Brandon S. Sheffield, David F. Schaeffer
Published 2017-09-01

Investigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatment

by Abdulaziz Alhussan, Kyle Bromma, Ece Pinar Demirci Bozdoğan, Andrew Metcalfe, Joanna Karasinska, Wayne Beckham, Abraham S. Alexander, Daniel J. Renouf, David F. Schaeffer, Devika B. Chithrani
Published 2021-05-01

Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

by Leah M Prentice, Ruth R Miller, Jeff Knaggs, Alborz Mazloomian, Rosalia Aguirre Hernandez, Patrick Franchini, Kourosh Parsa, Basile Tessier-Cloutier, Anna Lapuk, David Huntsman, David F Schaeffer, Brandon S Sheffield
Published 2018-01-01

Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system

by Petra W. C. Lee, Angela C. Bedard, Setareh Samimi, Vivienne K. Beard, Quan Hong, James E. J. Bedard, Blake Gilks, David F. Schaeffer, Robert Wolber, Janice S. Kwon, Howard J. Lim, Sophie Sun, Kasmintan A. Schrader
Published 2020-09-01

siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell GrowthSummary

by Shane P. Duggan, Catherine Garry, Fiona M. Behan, Sinead Phipps, Hiromi Kudo, Murat Kirca, Abdul Zaheer, Sarah McGarrigle, John V. Reynolds, Robert Goldin, Steve E. Kalloger, David F. Schaeffer, Aideen Long, Jessica Strid, Dermot Kelleher
Published 2018-01-01

Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma

by Julia R. Naso, James T. Topham, Joanna M. Karasinska, Michael K.C. Lee, Steve E. Kalloger, Hui‐li Wong, Jessica Nelson, Richard A. Moore, Andrew J. Mungall, Steven J.M. Jones, Janessa Laskin, Marco A. Marra, Daniel J. Renouf, David F. Schaeffer
Published 2021-02-01

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers

by Deirdre Weymann, Samantha Pollard, Brandon Chan, Emma Titmuss, Alexandra Bohm, Janessa Laskin, Steven J. M. Jones, Erin Pleasance, Jessica Nelson, Alexandra Fok, Howard Lim, Aly Karsan, Daniel J. Renouf, Kasmintan A. Schrader, Sophie Sun, Stephen Yip, David F. Schaeffer, Marco A. Marra, Dean A. Regier
Published 2021-08-01

Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.

by Brandon S Sheffield, Anna V Tinker, Yaoqing Shen, Harry Hwang, Hector H Li-Chang, Erin Pleasance, Carolyn Ch'ng, Amy Lum, Julie Lorette, Yarrow J McConnell, Sophie Sun, Steven J M Jones, Allen M Gown, David G Huntsman, David F Schaeffer, Andrew Churg, Stephen Yip, Janessa Laskin, Marco A Marra
Published 2015-01-01

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening

by Carol Cremin, Michael Kuan‐Ching Lee, Quan Hong, Carolyn Hoeschen, Anna Mackenzie, Katherine Dixon, Mary McCullum, Jennifer Nuk, Steve Kalloger, Joanna Karasinska, Charles Scudamore, Peter T. W. Kim, Fergal Donnellan, Eric C. S. Lam, Howard J. Lim, Cynthia L. Neben, Will Stedden, Alicia Y. Zhou, David F. Schaeffer, Sophie Sun, Daniel J. Renouf, Kasmintan A. Schrader
Published 2020-06-01